In this study, we found that the MoRAL score performed better in predicting the risk of tumor recurrence after LDLT among other currently available models, including the MC, current standard of care, and several other risk scores, which use AFP and tumor burden, including the WCM model [13], AFP model [18], UCSF or up-to-seven and AFP [19], and Metroticket 2.0 model [21]. Here, AFP is linked to neoplasm.